JAKE MONAGHAN: Open Payments
NPI 1588408702 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $52 |
| Stryker Corporation | 1 | $41 |
| Lilly USA, LLC | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $29 |
| PFIZER INC. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| Sonex Health, Inc. | 1 | $5 |
Products named: QULIPTA, MAKO, MOUNJARO, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), PREVNAR 20, RECORLEV, TRELEGY ELLIPTA, TZIELD.
Industry payments across ID — which companies pay providers there.
